Starpharma Holdings Limited (ASX:SPL – Get Free Report) insider Russell Basser bought 200,000 shares of the business’s stock in a transaction dated Friday, September 13th. The shares were bought at an average cost of A$0.09 ($0.06) per share, with a total value of A$18,600.00 ($12,567.57).
Starpharma Price Performance
The company has a debt-to-equity ratio of 12.55, a quick ratio of 5.65 and a current ratio of 4.94.
About Starpharma
Recommended Stories
- Five stocks we like better than Starpharma
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Beaten-Down Stocks Ready for a Comeback
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Stocks to Neutralize Market Volatility and Build Wealth
- High Flyers: 3 Natural Gas Stocks for March 2022
- How Much Can You Make in Stocks in One Month?
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.